Chinese herbs with standard TB treatment for lung health
Part of Infections clinical trials.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with pulmonary tuberculosis (lung TB).
- You have not started TB treatment yet, or have taken the standard 4-drug regimen (HRZE) for less than 1 week.
- You have symptoms like shortness of breath, tiredness, weak pulse, plus at least one of: coughing up blood, sweating at night, poor appetite, or a red tongue with thin coating.
- You are not currently on other Chinese herbal medicines for TB and have no drug-resistant TB.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding traditional Chinese medicine to standard treatment helps people with a lung infection called Mycobacterium abscessus. It may improve recovery and reduce side effects.
This trial tests a Chinese herbal formula (YSQTG) combined with standard immunotherapy and chemotherapy for people newly diagnosed with extensive-stage small cell lung cancer. The goal is to see if adding YSQTG improves outcomes for patients with a specific traditional Chinese medicine pattern.
This study tests whether a modified herbal formula (Bufei Decoction) can help reduce symptoms like cough, fatigue, and shortness of breath in older adults after lung cancer surgery, and whether it improves survival.
This trial tests whether adding a traditional Chinese herbal medicine (Qiling Yiqi tablets) to standard HIV treatment can help raise CD4+ T-cell counts in people whose immune systems haven't fully recovered. It may offer a new option for those with persistently low counts despite effective viral suppression.
This study tests whether a traditional Chinese medicine pill, Yiqi Gubiao, can help people who have both COPD and active tuberculosis. The goal is to see if it improves breathing and overall health without interfering with standard TB treatment.
This trial tests a combination of two traditional Chinese herbal formulas (Yinqiaosan and Maxingganshitang) to see if they can help people with mild to moderate COVID-19 recover faster. It's for adults who have had symptoms for no more than 3 days and have been diagnosed with a specific Chinese medicine pattern.
Hear when a new Adjuvant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.